Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa

Infection and Immunity

Volumn 68, Issue 8, 2000, Pages 4585-4592

  Cheung, Dorothy O Y ^a   Halsey, Keith ^a   Speert, David P ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEARANCE; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HOST RESISTANCE; INFECTION SENSITIVITY; KLEBSIELLA PNEUMONIAE; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL;

ANIMALS; CELL LINE; CLODRONIC ACID; KLEBSIELLA PNEUMONIAE; LIPOSOMES; LIVER; LUNG; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN;

EID: 0033915314     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.8.4585-4592.2000     Document Type: Article

References (29)

1. Barghouthi, S., K. D. E. Everett, and D. P. Speert. 1995. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages. J. Immunol. 154:3420-3428.
2. Berg, J. T., S. T. Lee, T. Thepen, C. Y. Lee, and M. F. Tsan. 1993. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J. Appl. Physiol. 74:2812-2819.
3. Berger, M., T. M. Norvell, M. F. Tosi, S. N. Emancipator, M. W. Konstan, and J. R. Schreiber. 1994. Tissue-specific Fcγ and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr. Res. 35:68-77.
4. Broug-Holub, E., G. B. Toews, J. F. Van Iwaarden, R. M. Strieter, S. L. Kunkel, R. Paine III, and T. J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 65:1139-1146.
5. Buret, A., M. L. Dunkley, G. Pang, R. L. Clancy, and A. W. Cripps. 1994. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1α. Infect. Immun. 62:5335-5343.
6. Butterick, C. J., D. A. Williams, L. A. Boxer, R. A. Jersild, Jr., N. Mantich, C. Higgins, and R. L. Baehner. 1981. Changes in energy metabolism, structure and function in alveolar macrophages under anaerobic conditions. Br. J. Haematol. 48:523-532.
7. Campa, M., M. Bendinelli, and H. Friedman. 1993. Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York, N.Y.
8. Everett, K. D. E., S. Barghouthi, and D. P. Speert. 1996. In vitro culture of murine peritoneal and alveolar macrophages modulates phagocytosis of Pseudomonas aeruginosa and glucose transport. J. Leukoc. Biol. 59:539-544.
9. Finlay, W. H., and J. P. Wong. 1998. Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin. Int. J. Pharm. 167:121-127.
10. Goodall, G. J., C. J. Bagley, M. A. Vadas, and A. F. Lopez. 1993. A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 8:87-97.
11. Greenberg, S. 1995. Signal transduction of phagocytosis. Trends Cell Biol. 5:93-99.
12. Hancock, R. E. W., and D. P. Speert. 1996. Antibiotics for Pseudomonas and related infections, p. 245-266. In J. A. Dodge, D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis - current topics, vol. 3. John Wiley and Sons, Toronto. Canada.
13. Hashimoto, S., J. F. Pittet, K. Hong, H. Folkesson, G. Bagby, L. Kobzik, C. Frevert, K. Watanabe, S. Tsurufujia. and J. Wiener-Kronish. 1996. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am. J. Physiol. 270:L819-L824.
14. Hauschildt, S., and B. Kleine. 1995. Bacterial stimulators of macrophages. Int. Rev. Cytol. 161:263-331.
15. Hickman-Davis, J. M., S. M. Michalek, J. Gibbs-Erwin, and J. R. Lindsey. 1997. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect. Immun. 65:2278-2282.
16. Kooguchi, K., S. Hashimoto, A. Kobayashi, Y. Kitamura, I. Kudoh, J. Wiener-Kronish, and T. Sawa. 1998. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 66:3164-3169.
17. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Investig. 99:2110-2117.
18. Naito, M., H. Nagai, S. Kawano, H. Umezu, H. Zhu, H. Moriyama, T. Yamamoto, H. Takatsuka, and Y. Takei. 1996. Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J. Leukoc. Biol. 60:337-344.
19. Ozaki, R., M. Maeda, H. Hayashi, Y. Nakamura, H. Moriguchi, T. Kamei, S. Yasuoka, and T. Ogura. 1989 Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Am. Rev. Respir. Dis. 140:1595-1601.
20. Perry, D. G., and W. J. Martin II. 1995. Fluorescent liposomes as quantitative markers of phagocytosis by alveolar macrophages. J. Immunol. Methods 181:269-285.
21. Speert, D. P. 1994. Pseudomonas aeruginosa infections in patients with cystic fibrosis, p. 183-236. In A. L. Baltch and R. P. Smith (ed.), Pseudomonas aeruginosa: infections and treatment. Marcel Dekker, Inc., New York, N.Y.
22. Speert, D. P., and S. Gordon. 1992. Phagocytosis of unopsonized Pseudomonas aeruginosa by murine macrophages is a two-step process requiring glucose. J. Clin. Investig. 90:1085-1095.
23. Speert, D. P., and L. Thorson. 1991. Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing. Infect. Immun. 59:1893-1898.
24. Stokes, R. W., L. M. Thorson, and D. P. Speert. 1998. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient. J. Immunol. 160:5514-5521.
25. Tang, H., M. Kays, and A. Prince. 1995. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63:1278-1285.
26. Tsuji, C., M. U. Minhaz, S. Shioya, M. Fukahori, T. Tanigaki, and H. Nakazawa. 1998. The importance of polymorphonuclear leukocytes in lipopolysaccharide-induced superoxide anion production and lung injury: ex vivo observation in rat lungs. Lung 176:1-13.
27. Van Rooijen, N., and A. Sanders. 1997. Elimination, blocking, and activation of macrophages: three of a kind? J. Leukoc. Biol. 62:702-709.
28. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174:83-93.
29. Wong, S. Y. C., L. M. Guerdoud, A. Cantin, and D. P. Speert. 1999 Glucose stimulates phagocytosis of unopsonized Pseudomonas aeruginosa by cultivated human alveolar macrophages. Infect. Immun. 67:16-21.